id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2363-0001,FDA,FDA-2020-E-2363,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T14:46:23Z,,0,0,09000064849d6369
FDA-2020-E-2363-0002,FDA,FDA-2020-E-2363,"Patent Term Extension Application for ENSPRYNG® Patent No 10,662,245",Other,Application,2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T14:47:19Z,,0,0,09000064849d636a